160 related articles for article (PubMed ID: 19188913)
1. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
[TBL] [Abstract][Full Text] [Related]
2. A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis.
Flanc RS; Ma FY; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
Kidney Int; 2007 Sep; 72(6):698-708. PubMed ID: 17597698
[TBL] [Abstract][Full Text] [Related]
3. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
Amos LA; Ma FY; Tesch GH; Liles JT; Breckenridge DG; Nikolic-Paterson DJ; Han Y
J Cell Mol Med; 2018 Sep; 22(9):4522-4533. PubMed ID: 29998485
[TBL] [Abstract][Full Text] [Related]
4. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis.
Abraham AP; Ma FY; Mulley WR; Nikolic-Paterson DJ; Tesch GH
Nephrology (Carlton); 2018 Feb; 23(2):183-189. PubMed ID: 27862656
[TBL] [Abstract][Full Text] [Related]
7. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
Takeda S; Takahashi M; Sado Y; Takeuchi K; Hakamata Y; Shimizu H; Kaneko T; Yamamoto H; Ito C; Ookawara S; Asano Y; Kusano E; Kobayashi E
Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626
[TBL] [Abstract][Full Text] [Related]
8. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation.
Huang XR; Holdsworth SR; Tipping PG
Kidney Int; 1994 Jul; 46(1):69-78. PubMed ID: 7523756
[TBL] [Abstract][Full Text] [Related]
9. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Mu W; Atkins RC
Clin Exp Immunol; 1997 Nov; 110(2):233-40. PubMed ID: 9367407
[TBL] [Abstract][Full Text] [Related]
10. Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis.
Stambe C; Atkins RC; Hill PA; Nikolic-Paterson DJ
Kidney Int; 2003 Dec; 64(6):2121-32. PubMed ID: 14633134
[TBL] [Abstract][Full Text] [Related]
11. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated renal injury is dependent on signaling via the JNK pathway.
Ikezumi Y; Hurst L; Atkins RC; Nikolic-Paterson DJ
J Am Soc Nephrol; 2004 Jul; 15(7):1775-84. PubMed ID: 15213265
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
14. Macrophage metalloelastase as a major factor for glomerular injury in anti-glomerular basement membrane nephritis.
Kaneko Y; Sakatsume M; Xie Y; Kuroda T; Igashima M; Narita I; Gejyo F
J Immunol; 2003 Mar; 170(6):3377-85. PubMed ID: 12626598
[TBL] [Abstract][Full Text] [Related]
15. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
18. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects.
Tachibana S; Iyoda M; Matsumoto K; Wada Y; Suzuki T; Iseri K; Kanazawa N; Shibata T
Nephrol Dial Transplant; 2019 May; 34(5):774-782. PubMed ID: 29982644
[TBL] [Abstract][Full Text] [Related]
20. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
